All Episodes
Displaying 31 - 32 of 32 in total
Life Science SPACs: A Forward Look at this Evolving Asset Class
In this week’s episode Jonathan Gertler, Back Bay’s CEO and Managing Partner, is joined by Gregory Benning and Vasilios Kofitsas of Back Bay’s investment banking team ...
Gene Therapies: What’s to Come as The Industry Moves Forward
In this episode our host, Dr. Peter Bak, sits down with Brendan Wang and Kyle O’Neil of Back Bay Life Science Advisors to discuss the field of gene therapies and insig...